Cargando…

Immunotherapy for Cervical Cancer: Are We Ready for Prime Time?

The prognosis of invasive cervical cancer (CC) remains poor, with a treatment approach that has remained the same for several decades. Lately, a better understanding of the interactions between the disease and the host immune system has allowed researchers to focus on the employment of immune therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turinetto, Margherita, Valsecchi, Anna A., Tuninetti, Valentina, Scotto, Giulia, Borella, Fulvio, Valabrega, Giorgio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999051/ https://www.ncbi.nlm.nih.gov/pubmed/35408919 http://dx.doi.org/10.3390/ijms23073559

Ejemplares similares

Biomarkers of Central Nervous System Involvement from Epithelial Ovarian Cancer
por: Scotto, Giulia, et al.
Publicado: (2021)

Immuno-Metabolism and Microenvironment in Cancer: Key Players for Immunotherapy
por: Giannone, Gaia, et al.
Publicado: (2020)

The Role of PARP Inhibitors in the Ovarian Cancer Microenvironment: Moving Forward From Synthetic Lethality
por: Turinetto, Margherita, et al.
Publicado: (2021)

Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy
por: Valabrega, Giorgio, et al.
Publicado: (2021)

Role of Cyclin-Dependent Kinase Inhibitors in Endometrial Cancer
por: Giannone, Gaia, et al.
Publicado: (2019)

Management of Metastatic Endometrial Cancer: Physicians’ Choices Beyond the First Line. A MITO Survey
por: Giannone, Gaia, et al.
Publicado: (2022)

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
por: Mittica, Gloria, et al.
Publicado: (2020)

Cancer Biomarkers: Are We Ready for the Prime Time?
por: Mishra, Alok, et al.
Publicado: (2010)

Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications
por: Giannone, Gaia, et al.
Publicado: (2019)

Lynch syndrome-associated endometrial cancer patient with a rare novel germline likely pathogenic variant of MSH2 gene: A case report
por: Zumstein, L., et al.
Publicado: (2023)

Liquid biopsies, are we ready for prime time?
por: Normanno, Nicola, et al.
Publicado: (2023)

Kidney Xenotransplantation: Are We Ready for Prime Time?
por: dos Santos, Rafael Miyashiro Nunes
Publicado: (2023)

Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience
por: Tuninetti, Valentina, et al.
Publicado: (2020)

Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells
por: Capellero, Sonia, et al.
Publicado: (2022)

Noninvasive Electrocardiographic Mapping: Are We Ready for Prime Time?
por: Aryana, Arash, et al.
Publicado: (2015)

Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors
por: Arezzo, Francesca, et al.
Publicado: (2023)

Endoscopic ultrasound-guided gastroenterostomy: Are we ready for prime time?
por: Rimbaş, Mihai, et al.
Publicado: (2017)

Minimally invasive donor hepatectomy, are we ready for prime time?
por: Au, Kin Pan, et al.
Publicado: (2018)

Complement in Sickle Cell Disease: Are We Ready for Prime Time?
por: Varelas, Christos, et al.
Publicado: (2021)

Tissue-resident memory T cells in gastrointestinal cancer immunology and immunotherapy: ready for prime time?
por: Abdeljaoued, Syrine, et al.
Publicado: (2022)

From Uterus to Brain: An Update on Epidemiology, Clinical Features, and Treatment of Brain Metastases From Gestational Trophoblastic Neoplasia
por: Borella, Fulvio, et al.
Publicado: (2022)

REBOA: is it ready for prime time?
por: Doucet, Jay, et al.
Publicado: (2017)

Efficacy of Image Enhanced Endoscopy for Colorectal Polyps: Are we Ready for Prime Time?
por: Neumann, Helmut, et al.
Publicado: (2017)

Optical coherence tomography of the pancreatic and bile ducts: are we ready for prime time?
por: Tyberg, Amy, et al.
Publicado: (2020)

Role of Mediterranean diet in preventing platinum based gastrointestinal toxicity in gynecolocological malignancies: A single Institution experience
por: Ghisoni, Eleonora, et al.
Publicado: (2019)

Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
por: Borella, Fulvio, et al.
Publicado: (2022)

Correction: Clinical and Histopathological Predictors of Recurrence in Uterine Smooth Muscle Tumor of Uncertain Malignant Potential (STUMP): A Multicenter Retrospective Cohort Study of Tertiary Centers
por: Borella, Fulvio, et al.
Publicado: (2022)

Brain Metastases from Ovarian Cancer: Current Evidence in Diagnosis, Treatment, and Prognosis
por: Borella, Fulvio, et al.
Publicado: (2020)

Retrospective Analysis of the Correlation of MSI-h/dMMR Status and Response to Therapy for Endometrial Cancer: RAME Study, a Multicenter Experience
por: Tuninetti, Valentina, et al.
Publicado: (2023)

Bio-electrical impedance analysis in critically ill patients: are we ready for prime time?
por: Myatchin, Ivan, et al.
Publicado: (2019)

Is pocket ultrasound ready for prime time?
por: Galen, Benjamin T
Publicado: (2012)

Radiotherapy for HCC: Ready for prime time?
por: Bang, Andrew, et al.
Publicado: (2019)

Commentary: Almost ready for prime time
por: Wei, Lawrence M.
Publicado: (2020)

CGM in the Hospital: Is It Ready for Prime Time?
por: Buschur, Elizabeth O., et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Epithelial Ovarian Cancer: An Overview on Efficacy and Future Perspectives
por: Borella, Fulvio, et al.
Publicado: (2020)

Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study
por: Tuninetti, Valentina, et al.
Publicado: (2023)

Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
por: Giannotta, Claudia, et al.
Publicado: (2023)

Are We Right on Target? Is Comprehensive Genomic Profiling Ready for Prime Time in Resource-Constrained Settings?
por: Ghosh, Joydeep, et al.
Publicado: (2022)

Glucocorticoid therapy for trauma - ready for prime time?
por: Aleti, Venkata S, et al.
Publicado: (2012)

CT colonography screening: ready for prime time?
por: Heiken, Jay P.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_jv7ulk0tm1eur90tdbnlslobch